ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)

The literature review provides basic information about cerebral stroke as one of the leading medical and socio-economic problems that caused high levels of mortality and morbidity from stroke, unfavorable disability index. This fact confirms the need for the introduction of efficient preventive meas...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	E. Y. Kitaeva, V. V. Shprakh
Formato:	article
Lenguaje:	RU
Publicado:	Scientific Сentre for Family Health and Human Reproduction Problems 2017
Materias:	antiplatelet agents antiplatelet therapy secondary prevention ischemic stroke Science Q
Acceso en línea:	https://doaj.org/article/e1548c88a0fa453997fef65dba6a72a5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e1548c88a0fa453997fef65dba6a72a5
record_format	dspace
spelling	oai:doaj.org-article:e1548c88a0fa453997fef65dba6a72a52021-11-23T06:14:37ZANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)2541-94202587-959610.12737/article_59a614fdad5fa4.11405630https://doaj.org/article/e1548c88a0fa453997fef65dba6a72a52017-04-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/629https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596The literature review provides basic information about cerebral stroke as one of the leading medical and socio-economic problems that caused high levels of mortality and morbidity from stroke, unfavorable disability index. This fact confirms the need for the introduction of efficient preventive measures among the healthy population and among patients with a stroke. The basic principles of secondary prevention, as well as the primary, are minimizing the risk factors and drug therapy. Antiplatelet therapy is a key point in the treatment and secondary prevention in patients with an ischemic stroke. On the basis of evidence-based data with the characteristics of antiplatelet agents, included in clinical guidelines and standards for the treatment of patients with ischemic stroke. Patients with ischemic stroke, if there are no contraindications for the appointment of antiplatelet agents, are prescribed antiplatelet agents from the first day (aspirin, clopidogrel and others). Patients usually have to take these drugs constantly (for life). The drug of choice in patients with intolerance, contraindications or complications of therapy with acetylsalicylic acid, as well as in patients with a stroke and diabetes, peripheral arterial disease, coronary syndrome, is clopidogrel. The literature review shows the basic principles of selection and prescription of antiplatelet agents tactics to ischemic stroke patients at different stages of the disease. A balanced, pharmacotherapeutically safe approach to the use of antiplatelet agents is very important. It raises the question of the need to apply the principles of personalized medicine in patients with a stroke, including the prescription of antiplatelet agents.E. Y. KitaevaV. V. ShprakhScientific Сentre for Family Health and Human Reproduction Problemsarticleantiplatelet agentsantiplatelet therapysecondary preventionischemic strokeScienceQRUActa Biomedica Scientifica, Vol 2, Iss 2, Pp 109-113 (2017)
institution	DOAJ
collection	DOAJ
language	RU
topic	antiplatelet agents antiplatelet therapy secondary prevention ischemic stroke Science Q
spellingShingle	antiplatelet agents antiplatelet therapy secondary prevention ischemic stroke Science Q E. Y. Kitaeva V. V. Shprakh ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
description	The literature review provides basic information about cerebral stroke as one of the leading medical and socio-economic problems that caused high levels of mortality and morbidity from stroke, unfavorable disability index. This fact confirms the need for the introduction of efficient preventive measures among the healthy population and among patients with a stroke. The basic principles of secondary prevention, as well as the primary, are minimizing the risk factors and drug therapy. Antiplatelet therapy is a key point in the treatment and secondary prevention in patients with an ischemic stroke. On the basis of evidence-based data with the characteristics of antiplatelet agents, included in clinical guidelines and standards for the treatment of patients with ischemic stroke. Patients with ischemic stroke, if there are no contraindications for the appointment of antiplatelet agents, are prescribed antiplatelet agents from the first day (aspirin, clopidogrel and others). Patients usually have to take these drugs constantly (for life). The drug of choice in patients with intolerance, contraindications or complications of therapy with acetylsalicylic acid, as well as in patients with a stroke and diabetes, peripheral arterial disease, coronary syndrome, is clopidogrel. The literature review shows the basic principles of selection and prescription of antiplatelet agents tactics to ischemic stroke patients at different stages of the disease. A balanced, pharmacotherapeutically safe approach to the use of antiplatelet agents is very important. It raises the question of the need to apply the principles of personalized medicine in patients with a stroke, including the prescription of antiplatelet agents.
format	article
author	E. Y. Kitaeva V. V. Shprakh
author_facet	E. Y. Kitaeva V. V. Shprakh
author_sort	E. Y. Kitaeva
title	ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
title_short	ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
title_full	ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
title_fullStr	ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
title_full_unstemmed	ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
title_sort	antiplatelet agents in the treatment and secondary prevention of ischemic stroke (review of literature)
publisher	Scientific Сentre for Family Health and Human Reproduction Problems
publishDate	2017
url	https://doaj.org/article/e1548c88a0fa453997fef65dba6a72a5
work_keys_str_mv	AT eykitaeva antiplateletagentsinthetreatmentandsecondarypreventionofischemicstrokereviewofliterature AT vvshprakh antiplateletagentsinthetreatmentandsecondarypreventionofischemicstrokereviewofliterature
_version_	1718417040093478912

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)

Ejemplares similares